Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
IQ-AI Limited (GB:IQAI)
LSE:IQAI
Holding GB:IQAI?
Track your performance easily
IQAI Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range0.93p - 5.15p
Previous Close1.45p
Volume192.12K
Average Volume (3M)1.56M
Market Cap
£3.21M
Enterprise Value3.08M
Total Cash (Recent Filing)£138.75K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.61
Next Earnings
May 06, 2025EPS EstimateN/A
Last Dividend Ex-Date
Apr 06, 2011Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding221,709,789
10 Day Avg. Volume341,193
30 Day Avg. Volume1,558,971
Standard Deviation0.29
R-Squared0.23
Alpha0.00113
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)5.28
Price to Cash Flow (P/CF)12.70
P/FCF Ratio30.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IQ-AI Limited News
PremiumCompany Announcements
IQ-AI Expands Imaging Solutions with GE HealthCare
PremiumCompany Announcements
IQ-AI Limited Welcomes Brain Tumor Expert to Board
PremiumCompany Announcements
IQ-AI Limited Eyes Revenue Growth and New Partnerships
PremiumCompany Announcements
Braveheart Investment Group Acquires Major Stake in IQ-AI Limited
PremiumCompany Announcements
IQ-AI Limited Reports Progress and New Milestones
PremiumCompany Announcements
IQ-AI Limited Reports Major Shareholding Change
PremiumCompany Announcements
IQ-AI CEO Sells Shares, Voting Rights Drop to ZeroPremiumCompany Announcements
Braveheart Investment Group Secures Major Stake in IQ-AIOptions Prices
Currently, No data available
---
Ownership Overview
IQAI FAQ
What was IQ-AI Limited’s price range in the past 12 months?
IQ-AI Limited lowest share price was 0.93p and its highest was 5.15p in the past 12 months.
What is IQ-AI Limited’s market cap?
Currently, no data Available
When is IQ-AI Limited’s upcoming earnings report date?
IQ-AI Limited’s upcoming earnings report date is May 06, 2025 which is in 134 days.
How were IQ-AI Limited’s earnings last quarter?
IQ-AI Limited released its earnings results on Aug 13, 2024. The company reported -0.001p earnings per share for the quarter, missing the consensus estimate of N/A by -0.001p.
Is IQ-AI Limited overvalued?
According to Wall Street analysts IQ-AI Limited’s price is currently Overvalued.
Does IQ-AI Limited pay dividends?
IQ-AI Limited pays a Notavailable dividend of 0.8p which represents an annual dividend yield of N/A. See more information on IQ-AI Limited dividends here
What is IQ-AI Limited’s EPS estimate?
IQ-AI Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IQ-AI Limited have?
IQ-AI Limited has 221,709,800 shares outstanding.
What happened to IQ-AI Limited’s price movement after its last earnings report?
IQ-AI Limited reported an EPS of -0.001p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.696%.
Which hedge fund is a major shareholder of IQ-AI Limited?
Currently, no hedge funds are holding shares in GB:IQAI
---
IQ-AI Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-66.89%
12-Months-Change
Fundamentals
Return on Equity
-140.75%
Trailing 12-Months
Asset Growth
-3.63%
Trailing 12-Months
Company Description
IQ-AI Limited
IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on proven technologies. Its geographical segment includes Jersey and the United States of America. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a strong neuroimaging product portfolio.
---
Technical Analysis
EKF Diagnostics Holdings
―
Ovoca Gold
―
Synairgen
―
HemoGenyx Pharmaceuticals Plc
―
---